Example: Heart Attack

Search clinical trials for: Shiga Toxins

Total 9 results

    • NCT00004465
      Terminated
      Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
      Conditions: Hemolytic Uremic Syndrome
    • NCT02205541
      Completed
      Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
      Conditions: Hemolytic Uremic Syndrome of Childhood
    • NCT01410916
      Completed
      Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
      Conditions: Shiga-like Toxin-producing Escherichia Coli
    • NCT03275792
      Withdrawn
      Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
      Conditions: Hemolytic-Uremic Syndrome
    • NCT03388216
      Completed
      Anti-Shiga Toxin Hyperimmune Equine Immunoglobulin F(ab')2 Fragment (INM004) in Healthy Volunteers
      Conditions: Healthy Volunteers
    • NCT01252199
      Completed
      Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
      Conditions: Shiga Toxin Producing Bacterial Infection
    • NCT04132375
      Suspended
      Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
      Conditions: Bloody Diarrhea; STEC, Unspecified; Hemolytic-Uremic Syndrome; Pediatric Kidney Disease
    • NCT01406288
      Completed
      Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
      Conditions: Hemolytic-uremic Syndrome; Escherichia Coli Infections
    • NCT03362970
      Recruiting
      Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia
      Conditions: Diarrhea Bloody
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations